HYPROMELLOSE 2910 (15000 MPA.S)

Suggest One No specific molecular structure known for this excipient.

CAS

9004653

UNII

288VBX44JC

SYNONYMS

ZINC ID(s)

Availability

Present in 0 ZINC catalogs

There has not been any activity reported at 10μM or less for this excipient (per ChEBML)

This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).

Analogs cannot be located as there is no structure provided for this compound. Try a search by name.

Route	Formulation	Per Unit Dose
Nasal	Solution, Spray	0.1%
Nasal	Spray	0.1%
Nasal	Spray, Metered	0.1%
Ophthalmic	Solution	0.5%
Ophthalmic	Suspension	0.5%
Ophthalmic	Suspension, Drops	0.5%
Oral	Capsule	40.55MG
Oral	Capsule, Delayed Action	33.42MG
Oral	Capsule, Enteric Coated Pellets	13.82MG
Oral	Capsule, Extended Release	10.6MG
Oral	Capsule, Hard Gelatin	2MG
Oral	Capsule, Sustained Action	21.1MG
Oral	Capsule, Sustained Action, Hard Gelatin	4.77MG
Oral	Granule, For Oral Suspension	26.6MG
Oral	Powder, For Reconstitution	1.59%
Oral	Powder, For Suspension	3%
Oral	Solution, Syrup	2.4%
Oral	Suspension	0.5%
Oral	Suspension, Sustained Action	24.08MG
Oral	Syrup	0.5%
Oral	Tablet (Immed./comp. Release), Film Coated	214.5MG
Oral	Tablet (Immed./comp. Release), Uncoated, Chewable	11.8MG
Oral	Tablet, Coated	29.25MG
Oral	Tablet, Controlled Release	20MG
Oral	Tablet, Delayed Action	4.47MG
Oral	Tablet, Delayed Action, Enteric Coated	19MG
Oral	Tablet, Enteric Coated Particles	445MG
Oral	Tablet, Extended Release	150MG
Oral	Tablet, Film Coated	60MG
Oral	Tablet, Multilayer, Coated	22MG
Oral	Tablet, Orally Disintegrating, Delayed Release	7MG
Oral	Tablet, Sustained Action	250MG
Oral	Tablet, Sustained Action, Coated	6.7MG
Oral	Tablet, Sustained Action, Film Coated	54MG
Oral-21	Tablet	0.75MG
Oral-28	Tablet	0.75MG

Data provided by OpenFDA